TED Ted Baker Plc

    Embargoed until 7am 19th May 2004

                                                                  19th May 2004

             Tepnel Life Sciences PLC (`Tepnel' or `the Company')              

                                 Board Change                                  

Tepnel Life Sciences PLC (AIM: TED), the UK-based international life sciences
products and services company, is pleased to announce that it has appointed
Andrew John Matthew Clark PhD to join the Company as a Non-Executive Director.

Andrew Clark brings with him a wealth of experience in investment management
from the life science sector. Andrew acts as a consultant for Reabourne
Technology Investment Management Ltd, which he co-founded in 1995. The company
manages the Finsbury Technology Trust, Finsbury Life Sciences Investment Trust,
Consulta Technology Fund and Close Finsbury Universal Life Sciences Fund. Prior
to this role he held several positions including UK and European Biotechnology
Analyst at Barings. Andrew earned his PhD in Neuroscience from the University
of St Andrews. 

Alec Craig, Chairman, commented: "We welcome the appointment of Andrew Clark to
the Board as an independent Non-Executive Director. His long standing
experience in the industry will not only expand Tepnel Life Sciences
capabilities, but will also deliver access to a large number of additional
industry and investor contacts."

Enquiries:

Gron Ffoulkes-Davies, Finance Director, Tepnel Life               0161 946 2200
Sciences PLC                                                                   
                                                                               
Yvonne Alexander, De Facto Communications plc                     0207 940 1000



END

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024

Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024